EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy.

Authors

Comelli, Agnese; Focà, Emanuele; Sansone, Emanuele; Tomasi, Cesare; Albini, Elisa; Quiros-Roldan, Eugenia; Tomasoni, Lina Rachele; Sala, Emma; Bonfanti, Carlo; Caccuri, Francesca; Caruso, Arnaldo; De Palma, Giuseppe; Castelli, Francesco; Calistri, Paolo

Abstract

Background: COVID-19 pandemic is requesting unprecedented efforts by health-care workers (HCWs) in all countries, and especially in Italy during the first semester of 2020. Methods: This is a retrospective, observational study conducted at the Spedali Civili General Hospital, in Brescia, Northern Italy during the SARS CoV-2 pandemic in the first semester of 2020. Serum samples from HCWs were tested for SARS-CoV-2 spike protein-specific antibodies. An online survey was used to collect demographic, clinical, and epidemiological data. Results: Of the 1893 HCWs included, 433 (22.9%) were found seropositive for SARS-CoV-2 IgG. The cumulative prevalence of SARS-CoV-2 infection (antibodies production or past positive RT-PCR on nasal/throat swab) was 25.1% (475/1893). Fifty-six out of 433 (13%) seropositive participants declared to have been asymptomatic during the study period. The development of COVID-19 signs or symptoms is the main determinant of seropositivity (OR: 11.3, p < 0.0001) along with their duration and severity. 40/290 (14.5%) HCWs with documented positive RT-PCR during the study period did not show any detectable antibody response. IgG levels positively correlate with age, COVID-19-compatible signs and symptoms experienced and their duration. Conclusions: In this study, carried out in one of the most affected areas in Europe, we demonstrate that most HCWs with COVID-19 related symptoms develop a spike protein-specific antibodies with potential neutralizing effect.

Subjects

NORTHERN Italy; BRESCIA (Italy); LOMBARDY (Italy); MEDICAL personnel; SARS-CoV-2; COVID-19 pandemic; COVID-19; ANTIBODY formation; VIRAL antibodies

Publication

Microorganisms, 2021, Vol 9, Issue 3, p488

ISSN

2076-2607

Publication type

Academic Journal

DOI

10.3390/microorganisms9030488

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved